posttreatment with the dihydropyridine calcium antagonist isradipine ( pn 200-110 ) , at a daily dose of 3 x 0.3 mg/kg sc , reduced the total infarct size by 30-40 % , determined by quantitative mri and confirmed by histology .
C2945601
dihydropyridine calcium antagonist
C0071304
isradipine